In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

ESC Guidelines on Dyslipidaemias 2016: new knowledge and tools for lipid management

ESC webinar on general cardiology

Add to calendar04/10/201618:00 04/10/201619:00 Europe/Paris ESC Guidelines on Dyslipidaemias 2016: new knowledge and tools for lipid management European Society of Cardiology contact@escardio.org DD/MM/YYYY
Primary care
Hypertension
Prevention
Dyslipidaemias
Online
event

Focus on

Aims
The student should be able to:

  • Estimate the risk of developing a CVD event and place the patient in the appropriate Dyslipidaemia Guideline risk category.
  • Arising, advise on which preventive strategy to apply.
  • Know the indications for initiating statin treatment.
  • Integrate the management of dyslipidaemias within the broader framework of CVD prevention.
  • Arising, discuss with the patient objectives and specific goals with regards to lipid and overall CVD risk management.

Objectives

  • Can demonstrate an understanding of total CVD risk.
  • Is able to demonstrate competence in estimating total CVD risk, particularly in relation to lipid measurements.
  • Shows understanding of the categories of CVD risk, particularly in relation to LDL cholesterol and other lipid measures.
  • Can relate these to management decisions especially regarding dyslipidaemias and the use of statins.
  • Can set appropriate lipid goals and develop a stepwise strategy to achieve these.
  • Can discuss with the patient lifestyle changes that are necessary to reach the lipid goals.
  • Can prescribe and monitor the use of lipid lowering drugs.